All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

MEDVi vs Noom Med: GLP-1 Program Comparison 2026

MEDVi vs Noom Med for GLP-1 weight loss in 2026. Compare their approaches to medication, behavior change, pricing, and long-term weight management.

By Dr. Rachel Nguyen, DO|Reviewed by Dr. David Kim, MD, FACE||

Medically Reviewed

Written by Dr. Rachel Nguyen, DO · Reviewed by Dr. David Kim, MD, FACE

MEDVi vs Noom Med: GLP-1 Program Comparison 2026 custom 2026 header image for Provider Comparisons
Custom header image for MEDVi vs Noom Med: GLP-1 Program Comparison 2026, Provider Comparisons, and better treatment decision-making.
In This Article

This article is part of our Provider Comparisons collection. See also: GLP-1 Guides | Peptide Guides

Search and AI answer brief

Practical answer: MEDVi vs Noom Med: GLP-1 Program Comparison 2026

MEDVi vs Noom Med for GLP-1 weight loss in 2026. Compare their approaches to medication, behavior change, pricing, and long-term weight management.

Short answer

MEDVi vs Noom Med for GLP-1 weight loss in 2026. Compare their approaches to medication, behavior change, pricing, and long-term weight management.

Search intent

This page answers a specific Provider Comparisons question rather than a generic overview.

What to verify

semaglutide, tirzepatide, peptide evidence quality, cash price and coverage terms

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

MEDVi vs Noom Med for GLP-1 weight loss in 2026. Compare their approaches to medication, behavior change, pricing, and long-term weight management.

Bottom line: Noom Med is the better choice for patients who want GLP-1 medication paired with a structured behavior change program designed to build lasting habits. MEDVi is the better choice for patients who want a clinically focused, physician-led program with thorough metabolic monitoring. Noom Med's psychology-based coaching is a genuine differentiator that addresses why people regain weight after stopping medication. MEDVi's lab work and physician oversight provide deeper medical infrastructure. Both are legitimate approaches, and the right pick depends on whether your bigger concern is clinical monitoring or building sustainable habits.

Quick Comparison

Feature MEDVi Noom Med
Monthly cost$249-$399/mo$149-$399/mo (varies by plan)
Consultation feeIncludedIncluded
Medications offeredCompounded semaglutide, tirzepatideCompounded and brand-name GLP-1s (insurance-dependent)
Behavior change programLimited nutritional guidanceYes (CBT-based coaching, daily curriculum)
Provider typeBoard-certified physiciansLicensed providers + health coaches
Lab workthorough panel includedNot typically included
App experienceBasic portalExcellent, well-established app
Food loggingNoYes (integrated)
Psychology-based coachingNoYes (core feature)
States available30+Most U.S. states

Pricing Breakdown

Noom Med's pricing structure varies based on the plan you choose. The basic Noom weight loss app starts around $60/month, but Noom Med (which includes GLP-1 medication) ranges from roughly $149-$399/month depending on medication type and whether insurance covers part of the cost. MEDVi's range is $249-$399/month.

Top Telehealth GLP-1 Providers Compared Overall Value Score 0 23 46 69 92 92 78 75 70 FormBlends Hims/Hers Ro Calibrate Based on pricing, support, and patient outcomes
Top Telehealth GLP-1 Providers Compared. Based on pricing, support, and patient outcomes.
View data table
Bar chart showing top telehealth glp-1 providers compared: FormBlends (92), Hims/Hers (78), Ro (75), Calibrate (70)
CategoryOverall Value ScoreDetail
FormBlends92From $299/mo, physician-led
Hims/Hers78Consumer brand, varies
Ro75Telehealth platform
Calibrate70Metabolic health focus
Illustration for MEDVi vs Noom Med: GLP-1 Program Comparison 2026

At comparable medication levels, the platforms are priced similarly. But Noom Med includes its behavior change curriculum, food logging tools, coaching, and daily lessons in that price. MEDVi includes thorough metabolic lab work. You're paying roughly the same amount, but the bundle is different.

One advantage Noom Med has: for patients whose insurance covers brand-name GLP-1s, Noom Med can work with those prescriptions, potentially reducing the medication portion of the cost significantly. MEDVi operates entirely outside insurance.

Medications Available

Both platforms offer compounded semaglutide and tirzepatide. Noom Med also has pathways for brand-name GLP-1 prescriptions (Wegovy, Zepbound) for patients with insurance coverage, giving it more medication flexibility.

Not sure which GLP-1 is right for you?

Take a 2-minute assessment and get a personalized recommendation after licensed provider review.

Take the Assessment →

The medication itself is only part of Noom Med's approach. Noom was built as a behavior change platform before it added GLP-1 prescribing. The company's core thesis is that medication helps patients lose weight, but behavior change helps them keep it off. This is supported by research showing that a significant percentage of patients regain weight after stopping GLP-1 medications if their habits haven't changed.

MEDVi focuses more narrowly on the medical side of the equation. The assumption is that physician oversight, lab monitoring, and structured dosing will produce the best clinical outcomes. MEDVi's providers may discuss lifestyle changes, but it isn't the centerpiece of the program.

Patient Experience

This is where Noom Med genuinely excels. The Noom app is one of the most developed health and wellness apps available. Daily lessons based on cognitive behavioral therapy (CBT) principles walk patients through the psychology of eating, habit formation, and emotional triggers. Integrated food logging, weight tracking, and coaching create a thorough daily engagement loop.

The app experience matters because GLP-1 medications are most effective when combined with lifestyle changes. Noom Med builds that structure into the platform rather than leaving it to the patient or a separate provider.

MEDVi's patient portal is utilitarian. It handles consultations, messaging, and prescription management without the engagement features that Noom provides. MEDVi's strength is clinical depth, not daily engagement.

Patients who want a platform that guides them through behavior change every day will find Noom Med more supportive. Patients who prefer a straightforward medical relationship without daily app engagement will find MEDVi less demanding.

Provider Quality and Support

MEDVi uses board-certified physicians for all consultations. Noom Med uses a mix of licensed medical providers for prescribing and a separate team of health coaches for behavioral support. The two-tier model means Noom Med patients interact with more people but may have less continuous contact with any single clinician.

Noom's health coaches aren't medical providers. They're trained in Noom's CBT-based methodology and provide accountability, encouragement, and behavioral guidance. For clinical questions and medication management, patients work with Noom Med's licensed providers.

MEDVi offers a more traditional single-provider relationship where the same physician manages your medication, reviews your labs, and conducts follow-ups. This continuity can be valuable for building trust and ensuring nothing gets lost between different team members.

Pros and Cons

MEDVi

Pros:

  • Physician-led with thorough lab monitoring
  • Structured medical oversight
  • Proactive follow-ups from a consistent provider
  • Straightforward program without daily engagement requirements

Cons:

  • No behavior change or coaching component
  • Basic digital platform
  • No food logging or habit tracking tools
  • Doesn't address weight maintenance after stopping medication

Noom Med

Pros:

  • CBT-based behavior change program built in
  • Excellent, engaging app with daily curriculum
  • Food logging and weight tracking integrated
  • Health coaching included
  • Can work with brand-name GLP-1s through insurance
  • Addresses long-term weight maintenance, not just loss

Cons:

  • No thorough lab work included
  • Medical provider may not be a physician
  • Daily engagement can feel demanding for some patients
  • Multiple touchpoints (coach + provider) can feel fragmented
  • Behavior change approach isn't for everyone

Who Should Choose MEDVi

MEDVi is the right choice for patients who want a medically focused program with physician oversight and lab monitoring. If you're less interested in behavior change coaching and more interested in clinical management of your GLP-1 therapy, MEDVi keeps things focused on the medical side. It's also a better fit for patients with comorbidities who benefit from thorough metabolic tracking.

Who Should Choose Noom Med

Noom Med is the better choice for patients who recognize that medication alone isn't a long-term solution. If you know your relationship with food needs to change alongside your medication, Noom Med provides the psychological framework and daily structure to make that happen. It's also worth choosing if your insurance covers brand-name GLP-1s, since Noom Med can work within that system.

How FormBlends Compares

FormBlends is a physician-supervised telehealth platform that pairs GLP-1 weight loss medication with peptide wellness therapy. It shares MEDVi's emphasis on physician oversight but adds treatment options that neither MEDVi nor Noom Med offer, including peptide protocols for recovery, energy, and metabolic health. FormBlends doesn't include a behavior change curriculum like Noom Med, but its broader wellness approach addresses multiple dimensions of health beyond weight alone. Patients curious about combining GLP-1 therapy with peptide wellness can learn more at FormBlends.com.

Frequently Asked Questions

Does Noom Med really help with long-term weight maintenance?

Noom's behavior change approach is supported by published research showing that patients who complete the program develop healthier eating habits and mindsets. Whether this fully prevents weight regain after stopping GLP-1 medication is still being studied, but the behavioral foundation Noom builds is a meaningful advantage over medication-only programs.

Can I use Noom Med without the coaching and daily lessons?

Technically yes, but you would be paying for features you aren't using. If you just want medication without the behavior change program, a platform like MEDVi or another GLP-1-focused telehealth service would be more cost-effective.

Does MEDVi provide any nutritional guidance?

MEDVi providers may discuss nutritional strategies during consultations, and some plans include basic dietary guidance. But it isn't a structured, daily curriculum like Noom Med offers. The nutritional component at MEDVi is supplementary, not central.

Which platform has better results?

Neither platform publishes independently verified outcome data that allows a fair comparison. Both use the same class of medications (compounded GLP-1s), which produce similar weight loss results in clinical studies. The differentiator is what happens after and alongside medication: MEDVi monitors your metabolic health. Noom Med works on your behavior. The best results likely come from a combination of both approaches.

Can I use my Noom subscription without adding the GLP-1 medication?

Yes. Noom's original weight loss app (without medication) is still available as a standalone subscription at a lower price. Noom Med is the add-on that includes GLP-1 prescribing on top of the core behavior change program.

Interested in physician-supervised GLP-1 therapy combined with peptide wellness protocols? Explore what FormBlends offers and see if it fits your approach to health.

Research Snapshot

Head-to-head comparison
Page type
Head-to-head comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
FormBlends official source
Official source
Calibrate official source
Official source
Hers official source
Official source
Hims official source
Official source
MEDVi official source
Official source
Noom Med official source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For MEDVi vs Noom Med: GLP-1 Program Comparison 2026, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Comparison decision path

Use this comparison to narrow the provider review question

Direct answer

MEDVi vs Noom Med: GLP-1 Program Comparison 2026 should help you decide which option deserves a clinical review, not force a one-size answer.

Evidence check

A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.

Safety check

The right choice can change based on history, medication interactions, side effects, budget, and availability.

Next step

After comparing, use the get-started flow to route your goals and health history into the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

MEDVi vs Noom Med for GLP-1 weight loss in 2026. Compare their approaches to medication, behavior change, pricing, and long-term weight management. The practical reason to read "MEDVi vs Noom Med: GLP-1 Program Comparison 2026" is to separate useful context from easy claims about cost and coverage. It sits in a comparison page where the details that matter most are access, cost, clinical fit, and what a licensed clinician should confirm and should help with comparison and decision support. Because this article has 10 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. Use the page to sharpen your next question, especially if your health history or medications change the risk profile.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Verify total monthly cost, refill timing, dose escalation pricing, and what is included before paying.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for MEDVi vs Noom Med

MEDVi vs Noom Med now carries extra 2026 context around semaglutide, tirzepatide, cash-pay pricing, medvi, noom, med, because those are the subtopics readers tend to compare before they trust a medical or wellness recommendation.

Instead of adding filler, this page keeps the named treatment terms, practical verification points, and next-step questions close to medvi vs noom med glp 1 program comparison 2026.

Readers should use the section to check current eligibility, pharmacy or provider policies, and safety questions with a licensed professional before acting.

MEDVi vs Noom Med custom 2026 image for provider comparisons on FormBlends

Custom 2026 image for MEDVi vs Noom Med, provider comparisons, and better treatment decision-making.

Image description: Unique image for this page covering MEDVi vs Noom Med, provider comparisons, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Disclosure: FormBlends is one of the providers discussed in this article. Our editorial team independently researches and verifies all pricing and claims. Pricing was last verified in March 2026. Read our editorial policy.

Written by Dr. Rachel Nguyen, DO

Obesity Medicine Specialist. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by Dr. David Kim, MD, FACE for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.